首页 | 本学科首页   官方微博 | 高级检索  
     


17 Fluorodeoxyglucose (FDG) positron emission tomography (PET) in Lymphoma
Affiliation:1. Department of Hematology/HCT, City of Hope, Duarte, California;2. Department of Haematology, VU University Medical Centre, Amsterdam, The Netherlands;3. Department of Biostatistics, City of Hope, Duarte, California;4. Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Aviv, Israel;5. Department of Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany;6. Department of Radiation Oncology, City of Hope, Duarte, California;1. Department of Internal Medicine, Division of Haematology, Medical University, Graz, Austria;2. Department of Radiology, Medical University, Graz, Austria;1. Institute of Haematology and Medical Oncology “L & A Seràgnoli”, University of Bologna, Bologna, Italy;2. Department of Cellular Biotechnology and Department of Haematology, University La Sapienza, Rome, Italy;3. Department of Haematology, University of Genoa, Genoa, Italy;4. Department of Haematology, S Eugenio Hospital, University ‘Tor Vergata’, Rome, Italy;5. Department of Haematology, University of Udine, Udine, Italy;6. Department of Internal Medicine and Haematology, Le Scotte Hospital, Siena, Italy;7. Division of Haematology, S Maria delle Croci Hospital, Ravenna, Italy;8. Department of Haematology, La Cattolica University, Rome, Italy;9. Division of Oncology, Rimini Hospital, Rimini, Italy;10. Division of Internal Medicine, Cesena Hospital, Cesena, Italy;11. Division of Oncology, Forlì Hospital, Forlì, Italy;12. Division of Haematology, Cagliari Hospital, Cagliari, Italy;13. Division of Haematology, Careggi Hospital, Florence, Italy;14. Department of Haematology, Federico II University, Naples, Italy;15. Department of Nuclear Medicine, Sant''Orsola-Malpighi Hospital, Bologna, Italy;1. Cancer Research UK Clinical Centre, Cancer Sciences Division, School of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK;1. Department of Clinical Hematology / Preclinical Investigation Laboratory, Institut Curie, Paris, France;2. Department of Onco-Hematology, CHU l''Archet, Nice, France;3. Department of Clinical Hematology, Centre Antoine Becquerel, Rouen, France;4. Department of Clinical Hematology, Institut Gustave Roussy, Villejuif, France;5. Department of Clinical Hematology, Centre Léon Bérard, Lyon, France;6. Department of Clinical Hematology, CHU, Pessac, France;7. Department of Clinical Hematology, CHU, Lille, France;8. Department of Clinical Hematology, Hôpital Lyon Sud, Pierre bénite, France;9. Department of Clinical Hematology, CHU, Nantes, France;10. Department of Clinical Hematology, CHU, Vandoeuvre les Nancy, France;11. Department of Clinical Hematology, Hôpital Necker, Paris, France;12. Department of Clinical Hematology, CHU, Toulouse, France;13. Department of Clinical Hematology, UCL, Yvoir, Belgium;14. Department of Pathology, Hôpital Saint-Louis, Paris, France;15. Department of Clinical Hematology, Hôpital Saint-Louis, Paris, France;1. Sarah Cannon Research Institute, Nashville, TN;2. Tennessee Oncology, PLLC, Nashville;3. Grand Rapids Clinical Oncology Program, Grand Rapids, MI;4. Consultants in Blood Disorders and Cancer, Louisville, KY
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号